Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Trellis Bioscience

Founders Lawrence Kauvar



Unlock datapoints

Portfolio analytics


News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 1
Average round size
The average size of a deal this fund participated in
Portfolio companies 1
Rounds per year 0.04
Lead investments 0
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Therapeutics
  • Biopharma
  • Health Care

Trellis Bioscience is the famous Corporate Investor, which was founded in 1998. The leading representative office of defined Corporate Investor is situated in the San Francisco. The venture was found in North America in United States.

The current fund was established by Lawrence Kauvar.

Deals in the range of 10 - 50 millions dollars are the general things for fund. The high activity for fund was in 2006. The increased amount of exits for fund were in 2019. The fund is constantly included in less than 2 investment rounds annually.

The usual cause for the fund is to invest in rounds with 5 partakers. The meaningful sponsors for the fund in investment in the same round are Polaris Partners, Morgenthaler Ventures, HealthCare Ventures. In the next rounds fund is usually obtained by Forbion Capital Partners.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Promedior Among the most successful fund investment fields, there are Therapeutics, Biopharma.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AMT China, Shanghai
AVENIR Moscow City, Moscow Oblast, Russian Federation
Avva Technology Pte Ltd Central, Central Region, Singapore
Canada Innovation Acceleration Investment -
CG Health Ventures Barcelona, Catalonia, Spain
Crescendix France, Ile-de-France, Paris
Crimson Capital Czechia, Prague, Prague
Eideard Venture Capital -
Gradiente Sgr Italy, Padua, Veneto
INDEE Japan Japan, Tokyo
Lucas Point Ventures New York, New York, United States
Metropolitan Venture Partners New York, New York, United States
Neff Capital Management -
Scripps Networks Knoxville, Tennessee, United States
Shanghai Xiangyi Touzi Guanli Youxian Gongsi China, Shanghai
SOUL FI Lisboa, Lisbon, Portugal
Venture Farm California, Irvine, United States
Zhejiang Ausun Pharmaceutical China, Jiangsu, Taizhou

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Health Care
$14M24 May 2006 Massachusetts, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Trellis Bioscience?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Average round size 14M
Rounds per year 0.04
Peak activity year 2006
Lead investments 0
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation


Health Care
$14M24 May 2006 Massachusetts, United States

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: